These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 23037715)
1. Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells. Tawadros T; Brown MD; Hart CA; Clarke NW Br J Cancer; 2012 Nov; 107(10):1737-44. PubMed ID: 23037715 [TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer. Brown M; Roulson JA; Hart CA; Tawadros T; Clarke NW Br J Cancer; 2014 Apr; 110(8):2099-108. PubMed ID: 24595005 [TBL] [Abstract][Full Text] [Related]
3. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906 [TBL] [Abstract][Full Text] [Related]
4. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells. Yang NY; Fernandez C; Richter M; Xiao Z; Valencia F; Tice DA; Pasquale EB Cell Signal; 2011 Jan; 23(1):201-12. PubMed ID: 20837138 [TBL] [Abstract][Full Text] [Related]
5. EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility. Parri M; Buricchi F; Giannoni E; Grimaldi G; Mello T; Raugei G; Ramponi G; Chiarugi P J Biol Chem; 2007 Jul; 282(27):19619-28. PubMed ID: 17449913 [TBL] [Abstract][Full Text] [Related]
6. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase. Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698 [TBL] [Abstract][Full Text] [Related]
7. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility. Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846 [TBL] [Abstract][Full Text] [Related]
8. Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer. Sachdeva A; Hart CA; Kim K; Tawadros T; Oliveira P; Shanks J; Brown M; Clarke N Br J Cancer; 2022 Oct; 127(7):1254-1262. PubMed ID: 35869144 [TBL] [Abstract][Full Text] [Related]
9. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808 [TBL] [Abstract][Full Text] [Related]
10. Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Navarro-Tito N; Robledo T; Salazar EP Exp Cell Res; 2008 Nov; 314(18):3340-55. PubMed ID: 18804105 [TBL] [Abstract][Full Text] [Related]
11. Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. Brown MD; Hart C; Gazi E; Gardner P; Lockyer N; Clarke N Br J Cancer; 2010 Jan; 102(2):403-13. PubMed ID: 19997104 [TBL] [Abstract][Full Text] [Related]
12. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Wykosky J; Debinski W Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825 [TBL] [Abstract][Full Text] [Related]
13. EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts. Giannoni E; Taddei ML; Parri M; Bianchini F; Santosuosso M; Grifantini R; Fibbi G; Mazzanti B; Calorini L; Chiarugi P J Mol Med (Berl); 2013 Jan; 91(1):103-15. PubMed ID: 22903544 [TBL] [Abstract][Full Text] [Related]
14. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene. Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143 [TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells. Villegas-Comonfort S; Castillo-Sanchez R; Serna-Marquez N; Cortes-Reynosa P; Salazar EP Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):169-77. PubMed ID: 24565443 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury. Park BH; Shin MH; Douglas IS; Chung KS; Song JH; Kim SY; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS Am J Respir Cell Mol Biol; 2018 Apr; 58(4):519-529. PubMed ID: 29216437 [TBL] [Abstract][Full Text] [Related]